Ne Plus Corp
Biotechnology company · Flushing, New York, United States
Ne Plus Corp is a biotechnology company headquartered in Flushing, New York, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $1.5 million sold in a notice filed in 2019.
Ne Plus at a glance
What does Ne Plus do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $1.5 million sold (2019).
Frequently asked questions about Ne Plus
Where is Ne Plus headquartered?
Ne Plus Corp is headquartered in Flushing, New York, United States.
What does Ne Plus do?
Ne Plus Corp is a biotechnology company.
When was Ne Plus founded?
The earliest incorporation on record for Ne Plus Corp is in 2019, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences